Mechanistically, PRKCSH interrupts TNFSF-mediated apoptotic signaling by promoting IGF1R activation in tumor cells without affecting the expression of TNFSF receptors, resulting in the inhibition of tumor cell death (Supplementary Fig. 11). Here, PRKCSH is linked to neoplasm.